# Tu Peso Ideal — Complete Reference

> Telehealth weight-management programs. Licensed providers issue patient-specific prescriptions for compounded semaglutide ($205/month monthly, or from $139/month effective on the prepaid 12-month plan) and compounded tirzepatide ($329/month monthly, or from $225/month effective on the prepaid 12-month plan), dispensed by U.S.-licensed 503A compounding pharmacies. Compounded medications are not FDA-approved.

Tu Peso Ideal is a telehealth weight-management company. Licensed healthcare providers issue patient-specific prescriptions for compounded semaglutide or compounded tirzepatide, which are dispensed by U.S.-licensed 503A compounding pharmacies. Tu Peso Ideal does not dispense or prescribe brand-name Ozempic®, Wegovy®, Mounjaro®, or Zepbound® (the FDA-approved brand-name products manufactured by Novo Nordisk and Eli Lilly). Compounded medications are not FDA-approved; the FDA has not reviewed them for safety, efficacy, or manufacturing quality. Patients complete an online medical assessment, get reviewed by a licensed provider, and receive medication shipped to their door.

- Website: https://tupesoideal.com
- Sister site: https://weightmethod.com (Weight Method — English version)
- Service area: All 50 U.S. states (telehealth)
- Languages: English and Spanish

---

## Company Overview

### What We Offer
- Online weight-management evaluations with licensed providers
- Patient-specific prescriptions for compounded semaglutide or compounded tirzepatide
- Medication dispensed and shipped by U.S.-licensed 503A compounding pharmacies
- Ongoing provider access and dosage management
- Patient portal for treatment tracking
- Tu Peso Ideal does NOT dispense or prescribe brand-name Ozempic®, Wegovy®, Mounjaro®, or Zepbound® (those are the FDA-approved brand-name products manufactured by Novo Nordisk and Eli Lilly)
- Compounded medications dispensed by Tu Peso Ideal's pharmacy partners are not FDA-approved

### Pricing
| Plan | Semaglutide | Tirzepatide | Type |
|------|------------|-------------|------|
| Monthly | $205/month | $329/month | Subscription (auto-renews monthly) |
| 3-month | $185/month | $296/month | Subscription (12-week commit, $50 activation on first invoice) |
| 12-month | from $139/month effective | from $225/month effective | Prepaid — one upfront payment, no auto-renewal |

All plans include: medication, provider review, shipping, and ongoing support. Promotion codes accepted at checkout.

### Eligibility Requirements
- Age: 18–100 years
- BMI ≥ 30 (obese) — eligible
- BMI ≥ 27 with comorbidities (diabetes, heart conditions) — eligible
- BMI < 27 without comorbidities — not eligible
- Tirzepatide recommended for BMI ≥ 35; semaglutide for BMI 27–34

---

## Patient Flow

### Step 1: Medical Assessment
Free online questionnaire at https://tupesoideal.com/cuestionario collecting:
- Goal weight
- Current height and weight (BMI calculated server-side)
- Age
- Health history: diabetes, heart conditions, current medications, prior GLP-1 use
- Contact information and state of residence
- Medication preference (semaglutide or tirzepatide)

### Step 2: Pricing & Checkout
- Patient selects plan duration (monthly, 3-month, or prepaid 12-month)
- Checkout via Stripe with promotion code support
- Payment processed securely

### Step 3: Shipping
- Patient provides shipping address
- Medications shipped from US pharmacies

### Step 4: Medical Consent
Four consent forms signed electronically:
- Telehealth informed consent
- Medication-specific consent (semaglutide or tirzepatide)
- HIPAA authorization
- Terms of service agreement

### Step 5: Provider Review
- Board-certified provider reviews medical history
- Prescription approved or denied with clinical reasoning
- If approved: order created, medication prepared for shipment

### Step 6: Fulfillment
Order status progression: pending → processing → shipped → delivered
- Tracking numbers provided for FedEx shipments
- Subscription renewals handled automatically

### Step 7: Ongoing Care
- Patient portal for treatment management
- Order tracking and history
- Consent document access
- Profile management

---

## Medications

### Semaglutide (active pharmaceutical ingredient)
- **Class:** GLP-1 receptor agonist
- **Mechanism:** Mimics GLP-1 hormone, reduces appetite, slows gastric emptying
- **Administration:** Weekly subcutaneous injection
- **FDA-approved brand-name products containing semaglutide:** Wegovy® (chronic weight management) and Ozempic® (type 2 diabetes), both manufactured by Novo Nordisk; plus Rybelsus® (oral, type 2 diabetes) and Oral Wegovy® (oral, weight management)
- **Common side effects (per FDA labeling of brand-name products):** Nausea, vomiting, diarrhea, constipation, abdominal pain
- **Titration:** Per FDA labeling of brand-name Wegovy, start low, increase gradually over 16-20 weeks to maintenance dose
- **Contraindications (per FDA labeling):** Personal/family history of medullary thyroid carcinoma, MEN2 syndrome
- **Tu Peso Ideal:** does NOT dispense brand-name Ozempic® or Wegovy®. Issues patient-specific prescriptions for compounded semaglutide dispensed by U.S.-licensed 503A pharmacies. Compounded semaglutide is not FDA-approved.
- **More info:** https://tupesoideal.com/medicamentos/semaglutide

### Tirzepatide (active pharmaceutical ingredient)
- **Class:** Dual GIP/GLP-1 receptor agonist
- **Mechanism:** Activates both GIP and GLP-1 receptors
- **Administration:** Weekly subcutaneous injection
- **FDA-approved brand-name products containing tirzepatide:** Zepbound® (chronic weight management) and Mounjaro® (type 2 diabetes), both manufactured by Eli Lilly
- **Common side effects (per FDA labeling of brand-name products):** Nausea, diarrhea, decreased appetite, vomiting, constipation
- **Titration:** Per FDA labeling of brand-name Zepbound, start at 2.5mg, increase every 4 weeks to maintenance dose
- **Contraindications (per FDA labeling):** Personal/family history of medullary thyroid carcinoma, MEN2 syndrome
- **Tu Peso Ideal:** does NOT dispense brand-name Mounjaro® or Zepbound®. Issues patient-specific prescriptions for compounded tirzepatide dispensed by U.S.-licensed 503A pharmacies. Compounded tirzepatide is not FDA-approved.
- **More info:** https://tupesoideal.com/medicamentos/tirzepatide

### Semaglutide vs Tirzepatide
| Factor | Semaglutide | Tirzepatide |
|--------|------------|-------------|
| Mechanism | GLP-1 receptor agonist | Dual GIP + GLP-1 receptor agonist |
| FDA-approved brand-name products | Ozempic® (diabetes), Wegovy® (weight management) — Novo Nordisk | Mounjaro® (diabetes), Zepbound® (weight management) — Eli Lilly |
| Injection frequency | Weekly | Weekly |
| Tu Peso Ideal compounded program (not FDA-approved) | $205/month monthly (from $139/mo effective on the prepaid 12-month plan) | $329/month monthly (from $225/mo effective on the prepaid 12-month plan) |

---

## Health Conditions Treated

### Obesity (BMI ≥ 30)
GLP-1 medications are FDA-approved for chronic weight management in adults with BMI ≥ 30. Clinical trials show sustained weight loss of 15-22% over 68-72 weeks.

### Overweight with Comorbidities (BMI ≥ 27)
Eligible when accompanied by: type 2 diabetes, cardiovascular disease, hypertension, dyslipidemia, or obstructive sleep apnea.

### Type 2 Diabetes
Semaglutide and tirzepatide are also used for glycemic control in type 2 diabetes under separate FDA-approved brand-name products that Tu Peso Ideal does not dispense or prescribe.

### PCOS (Polycystic Ovary Syndrome)
GLP-1 medications show promise for PCOS-related weight management and insulin resistance improvement, though not FDA-approved specifically for PCOS.

### Cardiovascular Risk Reduction
Semaglutide (SELECT trial) demonstrated 20% reduction in major adverse cardiovascular events in overweight/obese adults without diabetes.

---

## Insurance & Cost

### Tu Peso Ideal Compounded Program Pricing
Compounded semaglutide is $205/month monthly, or from $139/month effective on the prepaid 12-month plan; compounded tirzepatide is $329/month monthly, or from $225/month effective on the prepaid 12-month plan. The 3-month subscription lowers the monthly rate ($185 semaglutide / $296 tirzepatide) and carries a $50 activation fee on the first invoice. The 12-month plan is a single upfront payment — no auto-renewal. Compounded medications are not FDA-approved.

### Insurance Coverage
Coverage varies significantly by carrier, plan type, and state:
- **Blue Cross Blue Shield:** Variable by state; prior authorization typically required
- **Aetna:** Covers for BMI ≥ 30 or ≥ 27 with comorbidities; step therapy may apply
- **Cigna:** Commercial plans may cover; Medicare Advantage varies
- **UnitedHealthcare:** Prior authorization required; covers with documented medical necessity
- **Anthem:** Coverage depends on plan; employer-sponsored plans more likely to cover
- **Humana:** Medicare Advantage plans expanding coverage
- **Kaiser Permanente:** Integrated model; coverage varies by region

### Medicare & Medicaid
- Medicare Part D does not cover GLP-1s for weight loss (covers for diabetes only)
- Medicaid coverage varies by state; some states cover for obesity
- Legislative changes possible under the TREAT Act

---

## Content Library

### Educational Guides (https://tupesoideal.com/guias)
50+ bilingual guides covering:
- GLP-1 medication science and mechanisms
- Weight loss nutrition and lifestyle guidance
- Treatment expectations and timelines
- Managing side effects
- Exercise with GLP-1 medications
- Mental health and weight management

### Blog (https://tupesoideal.com/blog)
Regularly updated articles on:
- Latest GLP-1 research and FDA updates
- Patient stories and experiences
- Medication comparisons and analysis
- Cost and insurance updates
- Nutrition and lifestyle advice

### Telehealth Information (https://tupesoideal.com/telemedicina)
Guides on virtual healthcare:
- How online GLP-1 prescriptions work
- Telehealth safety and regulations
- State-by-state telehealth availability
- Virtual consultation process

### Dosage Resources
- Interactive dosage calculators for semaglutide and tirzepatide
- Titration schedules and timelines
- Syringe visual guides and concentration references

---

## Location Coverage

Tu Peso Ideal provides telehealth weight-loss care to patients in all 50 U.S. states. Educational, city-specific information is available for 3,161+ cities with population ≥ 10,000.

Browse by state: https://tupesoideal.com/estados
Browse by city: https://tupesoideal.com/clinica-perdida-de-peso

---

## Active-Ingredient Comparison

- [Semaglutide vs Tirzepatide](https://tupesoideal.com/comparar/semaglutida-vs-tirzepatida): Mechanism, FDA-approved brand-name products, brand-trial outcomes

---

## Frequently Asked Questions

**What is Tu Peso Ideal?**
Tu Peso Ideal is a telehealth weight-management company. Licensed providers issue patient-specific prescriptions for compounded semaglutide or compounded tirzepatide, dispensed by U.S.-licensed 503A compounding pharmacies. Tu Peso Ideal does not dispense or prescribe brand-name Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. Compounded medications are not FDA-approved.

**How much does it cost?**
The compounded semaglutide program is $205/month monthly (or from $139/month effective on the prepaid 12-month plan); the compounded tirzepatide program is $329/month monthly (or from $225/month effective on the prepaid 12-month plan). The 3-month plan is billed monthly at a lower rate ($185 / $296) with a $50 activation fee on the first invoice; the 12-month plan is a single upfront payment with no auto-renewal. Compounded medications are not FDA-approved.

**Do I need insurance?**
No. Tu Peso Ideal's compounded program is cash-pay and does not run through insurance. HSA/FSA funds may be used.

**How do I qualify?**
You must be 18+ years old with a BMI ≥ 30, or BMI ≥ 27 with a qualifying health condition (diabetes, heart disease, etc.).

**How long until I receive medication?**
After completing the assessment and payment, medical review typically takes 1-3 business days. Shipping takes 3-5 business days after approval.

**Is this safe?**
All prescriptions are reviewed by licensed healthcare providers. Compounded medications dispensed pursuant to Tu Peso Ideal prescriptions are prepared by U.S.-licensed 503A compounding pharmacies and are not FDA-approved; the FDA has not reviewed them for safety, efficacy, or manufacturing quality.

**Can I cancel my subscription?**
Monthly and 3-month plans are subscriptions: the monthly plan can be cancelled anytime, and the 3-month plan has a 12-week minimum commitment, then continues monthly until cancelled. The 12-month plan is a single prepaid payment with no auto-renewal — there is no recurring charge to cancel.

**Do you ship to my state?**
Tu Peso Ideal provides telehealth care in all 50 U.S. states.

**What if I'm not approved?**
If our provider determines GLP-1 medication is not appropriate for you, you will be notified with an explanation. No charge is made until after assessment.

---

## Contact & Legal

- Email: support@weightmethod.com
- Privacy Policy: https://tupesoideal.com/privacidad
- Terms of Service: https://tupesoideal.com/terminos

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication. Tu Peso Ideal prescriptions require medical review and approval by a licensed provider.